Venlafaxine: A novel antidepressant that has a dual mechanism of action

Depression

Volumn 4, Issue 2, 1996, Pages 48-56

  Andrews, J M ^a   Ninan, P T ^a   Nemeroff, C B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antidepressants; major depressive disorder; norepinephrine; reuptake inhibition; serotonin

Indexed keywords

ANTIDEPRESSANT AGENT; NORADRENALIN; SEROTONIN; VENLAFAXINE;

CONSTIPATION; DEPRESSION; HUMAN; INSOMNIA; NAUSEA; NERVOUSNESS; REVIEW; SEIZURE; SEXUAL DYSFUNCTION; SOMNOLENCE; VERTIGO;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; CYCLOHEXANOLS; DEPRESSIVE DISORDER; HUMANS; NOREPINEPHRINE; RECEPTORS, ADRENERGIC; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SYNAPTIC TRANSMISSION; TREATMENT OUTCOME;

EID: 0030482877     PISSN: 10626417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-7162(1996)4:2<48::AID-DEPR2>3.0.CO;2-B     Document Type: Review

References (54)